1.01-1.02 | The governing body leads a safety and quality culture, partners with consumers, sets priorities and the clinical governance framework, defines roles, monitors incident action and p | 1 |
1.03-1.06 | The organisation maintains a clinical governance framework that drives improvement, implements strategies for Aboriginal and Torres Strait Islander patients, weighs safety and qual | 1 |
1.07-1.09 | Policies, procedures and protocols are managed through a risk-based system with compliance monitoring, organisation-wide quality improvement systems measure and improve performance | 1 |
1.10 | Organisational risks are identified, documented, assessed with clinical and other data, reduced, reviewed, reported to workforce and consumers, and emergency and disaster plans are | 1 |
1.11-1.12 | Organisation-wide incident management and investigation systems support reporting by workforce and patients, involve them in review, feed back analyses, drive improvement and the r | 1 |
1.13-1.14 | Feedback from patients, carers, families and the workforce is sought regularly and used to improve, and an organisation-wide complaints management system encourages complaints, inv | 1 |
1.15-1.18 | The organisation knows the diversity and higher-risk groups among its consumers and plans care accordingly, keeps healthcare records available at the point of care, accurate, secur | 1 |
1.19-1.22 | Everyone, including board members, locums, agency, students and volunteers, is oriented to their safety and quality roles; training systems assess competency and needs, deliver man | 1 |
1.23-1.26 | Scope of clinical practice is defined, monitored and reviewed, clinicians are credentialed where relevant with the process monitored and improved, safety and quality roles are assi | 1 |
1.27-1.28 | Clinicians have ready access to best-practice guidelines, pathways, decision support and the Commission's clinical care standards, and systems monitor variation in practice and out | 1 |
1.29-1.33 | The environment and infrastructure are designed and maintained to maximise safety, areas at high risk of unpredictable behaviour have risk-minimising strategies and calm spaces, si | 0 |
2.01-2.02 | Clinicians apply the clinical governance and quality improvement systems to partnering with consumers: policies, risks, training, monitoring, improvement and reporting | 0 |
2.03-2.05 | A charter of rights consistent with the Australian Charter of Healthcare Rights is used and accessible, informed consent processes comply with law and best practice, and processes | 1 |
2.06-2.07 | Clinicians partner with patients and substitute decision-makers to plan, communicate, set goals and make decisions about current and future care, and the workforce is supported to | 0 |
2.08-2.10 | Communication is tailored to consumer diversity, consumers are involved in developing and reviewing patient information, and clinicians are supported to communicate so information | 1 |
2.11-2.14 | Consumers partner in governance, planning, design, measurement and evaluation, reflecting the diversity of users, and receive orientation, support and education; the organisation p | 0 |
3.01-3.04 | The clinical governance, quality improvement and consumer partnership systems are applied to infection prevention and control and antimicrobial stewardship: multidisciplinary teams | 0 |
3.05 | A surveillance strategy collects and uses data on healthcare-associated and other infections and on antimicrobial use and appropriateness, incorporates national and jurisdictional | 0 |
3.06-3.09 | Standard and transmission-based precautions consistent with the national infection control guidelines are implemented, risk-assessed with patients and workforce, supported by PPE p | 0 |
3.10-3.11 | A hand hygiene program consistent with the National Hand Hygiene Initiative audits compliance, addresses non-compliance against benchmarks, reports results and actions, and improve | 0 |
3.12-3.14 | Invasive medical devices are used and managed consistently with the national guidelines; the environment is kept clean, safe and hygienic with TGA-listed products, cleaning trainin | 1 |
3.15-3.16 | A risk-based workforce screening and immunisation program follows the Australian Immunisation Handbook and jurisdictional requirements, and workforce infection risks are managed th | 0 |
3.17 | Reusable equipment and devices are reprocessed consistently with national and international standards and manufacturers' guidance, critical and semi-critical items are traceable to | 0 |
3.18-3.19 | An antimicrobial stewardship program has a policy, current Australian therapeutic guidelines, a formulary with restrictions and approvals and the Antimicrobial Stewardship Clinical | 0 |
4.01-4.04 | Governance, quality improvement and consumer partnership systems are applied to medication management, and the scope of clinical practice for prescribing, dispensing and administer | 0 |
4.05-4.09 | A best possible medication history is taken and documented early, current orders are reconciled against it at presentation and transitions, allergies and adverse drug reactions are | 0 |
4.10-4.12 | Medication reviews are performed, prioritised by clinical need and documented with actions; patients receive information on their medicines needs and risks; and a current medicines | 0 |
4.13-4.15 | Medicines information and decision support tools are available to clinicians; medicines are stored, distributed, cold-chain managed and disposed of per manufacturers' directions, l | 0 |
5.01-5.06 | Governance, quality improvement and consumer partnership systems are applied to comprehensive care; systems support clinicians to develop, document and communicate care plans, prov | 0 |
5.07-5.13 | Integrated, timely screening and assessment identify risks of harm and social circumstances, Aboriginal and Torres Strait Islander status is routinely asked and recorded, advance c | 0 |
5.14-5.20 | Care is delivered, monitored and updated against the comprehensive care plan in partnership with patients, carers and families, and end-of-life care follows the National Consensus | 0 |
5.21-5.23 | Pressure injury prevention and wound management systems follow best-practice guidelines, clinicians inspect skin of at-risk patients in best-practice time frames, patients and fami | 0 |
5.24-5.26 | Falls systems consistent with best-practice guidelines cover prevention, minimising harm and post-fall management, equipment and tools promote safe mobility, and patients, carers a | 0 |
5.27-5.28 | Overnight services have food and fluid preparation and distribution systems with evidence-based nutrition care plans, and the workforce uses them to meet nutritional needs, monitor | 0 |
5.29-5.30 | A system for caring for patients with cognitive impairment or at risk of delirium incorporates best-practice recognition, prevention, treatment and management including the Deliriu | 0 |
5.31-5.32 | Systems support collaboration with patients, carers and families to identify risk of self-harm and suicide and respond safely and effectively to distressed patients, and follow-up | 0 |
5.33-5.36 | Situations that may precipitate aggression are identified and mitigated, patients at risk of aggression or violence are identified with de-escalation and safe management in collabo | 0 |
6.01-6.04 | Governance, quality improvement and consumer partnership systems are applied to clinical communication, and clinical communication processes support effective communication at iden | 0 |
6.05-6.06 | Approved patient identifiers are defined per best practice, at least three are required at registration and admission, when care, medicines, therapy and services are provided, and | 1 |
6.07-6.08 | The organisation and clinicians define the minimum information content, service-specific risks and the clinicians involved in clinical handover, and clinicians use structured hando | 0 |
6.09-6.11 | Critical information, alerts and risks are communicated in a timely way when they emerge or change to decision-making clinicians and to patients, carers and families per the patien | 1 |
7.01-7.03 | Governance, quality improvement and consumer partnership systems are applied to blood management: policies, risks, training, performance monitoring, improvement, outcome reporting, | 0 |
7.04-7.08 | Clinicians optimise patients' own blood, identify and manage bleeding risk and determine clinical need; blood management decisions, transfusion history and details are documented; | 0 |
7.09-7.10 | Blood and blood products are stored, distributed and handled safely and securely per manufacturers' directions, legislation and jurisdictional requirements, traced from entry to tr | 0 |
8.01-8.03 | Governance, quality improvement and consumer partnership systems are applied to recognising and responding to acute deterioration: policies, risks, training, monitoring and improve | 0 |
8.04-8.05 | Clinicians document individualised vital sign monitoring plans, monitor patients accordingly and graphically track observations to detect physiological deterioration; and for deter | 0 |
8.06-8.09 | Escalation protocols specify agreed vital sign and mental state triggers, emergency assistance criteria, unmanaged pain or distress and the worry or concern of workforce, patients, | 1 |
8.10-8.13 | Response processes ensure timely attendance by clinicians skilled to manage acute deterioration, rapid access at all times to a clinician who can deliver advanced life support on s | 0 |
NSQHS-INTRO | The NSQHS Standards: purpose, assessment and the structure of eight Standards, criteria and 148 actions | 0 |